Literature DB >> 12917939

Ionisers for chronic asthma.

K Blackhall1, S Appleton, C J Cates.   

Abstract

BACKGROUND: Previous reports have shown that ion content in the air may have an effect on respiratory function. Results from studies which test the efficacy of air ionisers to reduce asthma symptoms are often inconclusive and their use as a treatment for asthma remains debatable.
OBJECTIVES: We conducted a systematic review of the available evidence to determine the effectiveness of positive and negative ion generators in people with asthma. SEARCH STRATEGY: We searched the Cochrane Airways Group Asthma trials register (January 1966 to March 2003), Cochrane Central Register of Controlled Trials (Cochrane Library issue 2, 2003) as well as The Alternative Medicine Database AMED (1985 to March 2003). SELECTION CRITERIA: Randomised controlled trials (parallel or crossover design studies) comparing ionisers with dummy ionisers (being negative or positive ion emitters), in children or adults with chronic asthma. DATA COLLECTION AND ANALYSIS: Two reviewers independently assessed titles and abstracts of studies and assessed trial quality. Study quality was determined using two methods:The Cochrane approach to allocation concealment and the five point Jadad scale. MAIN
RESULTS: Six studies were selected for inclusion (106 participants). No results were combined as the studies were all of a crossover design. EFFECTS OF NEGATIVE ION GENERATORS (five studies)No study reported a significant difference in lung function between ionised and control air (morning Peak expiratory flow (PEF) - three studies; forced expiratory flow in one second (FEV1) - one study). There were no significant differences in symptoms or beta-2 agonist usage between ionised and control air in three studies. EFFECTS OF POSITIVE ION GENERATORS (one study)This study demonstrated that although positively ionised air was associated with a larger fall in FEV1 with exercise, this did not reach statistical significance. Baseline FEV1 was not demonstrated to be significantly different between treatment groups. REVIEWER'S
CONCLUSIONS: Based on the evidence currently available from randomised controlled trials, a recommendation cannot be given for the use of room air ionisers to reduce symptoms in patients with chronic asthma.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12917939     DOI: 10.1002/14651858.CD002986

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  6 in total

1.  Air cleaning technologies: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2005-11-01

Review 2.  From good intentions to proven interventions: effectiveness of actions to reduce the health impacts of air pollution.

Authors:  Luisa V Giles; Prabjit Barn; Nino Künzli; Isabelle Romieu; Murray A Mittleman; Stephan van Eeden; Ryan Allen; Chris Carlsten; Dave Stieb; Curtis Noonan; Audrey Smargiassi; Joel D Kaufman; Shakoor Hajat; Tom Kosatsky; Michael Brauer
Journal:  Environ Health Perspect       Date:  2010-08-20       Impact factor: 9.031

Review 3.  An integrative review of systematic reviews related to the management of breathlessness in respiratory illnesses.

Authors:  Chris D Bailey; Richard Wagland; Rasha Dabbour; Ann Caress; Jaclyn Smith; Alex Molassiotis
Journal:  BMC Pulm Med       Date:  2010-12-09       Impact factor: 3.317

Review 4.  Air ions and respiratory function outcomes: a comprehensive review.

Authors:  Dominik D Alexander; William H Bailey; Vanessa Perez; Meghan E Mitchell; Steave Su
Journal:  J Negat Results Biomed       Date:  2013-09-09

5.  The method quality of cross-over studies involved in Cochrane Systematic Reviews.

Authors:  Hong Ding; Guang Li Hu; Xue Yan Zheng; Qing Chen; Diane Erin Threapleton; Zeng Huan Zhou
Journal:  PLoS One       Date:  2015-04-13       Impact factor: 3.240

6.  No Concentration Decrease of House Dust Mite Allergens With Rising Altitude in Alpine Regions.

Authors:  Carina Grafetstätter; Johanna Prossegger; Herbert Braunschmid; Renata Sanovic; Penelope Hahne; Christina Pichler; Josef Thalhamer; Arnulf Hartl
Journal:  Allergy Asthma Immunol Res       Date:  2016-07       Impact factor: 5.764

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.